Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ezequiel M Fuentes-Panana

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cancers|March 31, 2018
The Immunomodulatory Capacity of an Epstein-Barr Virus Abortive Lytic Cycle: Potential Contribution to Viral TumorigenesisAbigail Morales-Sánchez, Ezequiel M Fuentes-Panana
Current Cancer Drug Targets|September 29, 2016
Epstein-Barr Virus-associated Gastric Cancer and Potential Mechanisms of OncogenesisAbigail Morales-Sanchez, Ezequiel M Fuentes-Panana
Immunological Reviews|July 13, 2007
Tonic B-cell and viral ITAM signaling: context is everythingShannon M Grande, Gregory Bannish, Ezequiel M Fuentes-Panana, et al.
Immunologic Research|July 15, 2003
Positive and negative selection during B lymphocyte developmentJohn G Monroe, Gregory Bannish, Ezequiel M Fuentes-Panana, et al.
Oncoimmunology|December 4, 2025
Wnt3a-expressing cancer stem cells impair CD8<sup>+</sup> TRM function, contributing to immunotherapy resistance in MelanomaJulián A Gajón, Angel Juarez-Flores, Fatima Mendoza-Roldan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cancers|March 31, 2018
The Immunomodulatory Capacity of an Epstein-Barr Virus Abortive Lytic Cycle: Potential Contribution to Viral TumorigenesisAbigail Morales-Sánchez, Ezequiel M Fuentes-Panana
Current Cancer Drug Targets|September 29, 2016
Epstein-Barr Virus-associated Gastric Cancer and Potential Mechanisms of OncogenesisAbigail Morales-Sanchez, Ezequiel M Fuentes-Panana
Immunological Reviews|July 13, 2007
Tonic B-cell and viral ITAM signaling: context is everythingShannon M Grande, Gregory Bannish, Ezequiel M Fuentes-Panana, et al.
Immunologic Research|July 15, 2003
Positive and negative selection during B lymphocyte developmentJohn G Monroe, Gregory Bannish, Ezequiel M Fuentes-Panana, et al.
Oncoimmunology|December 4, 2025
Wnt3a-expressing cancer stem cells impair CD8<sup>+</sup> TRM function, contributing to immunotherapy resistance in MelanomaJulián A Gajón, Angel Juarez-Flores, Fatima Mendoza-Roldan, et al.
Pageof 1